PURE BIOSCIENCE (PURE) earnings
PURE earnings moved a median of +2.29% by the close. Quarterly and annual PURE reports and results, each read against the price at its own news timestamp. Back to the PURE overview →
21 measured PURE earnings events.
Where these PURE earnings landedvs 20 measured PURE earnings reactions
| Middle 50% of PURE earnings reactions | -11.67% to +10.60% |
|---|---|
| Median reaction (to close) | +2.29% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 PURE earnings events with a measured close landed between -11.67% and +10.60%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PURE BIOSCIENCE, INC. For: Apr 30 | SEC filing · Form 10-Q | +0.00% | -12.14% | |
| PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results | Press release | +0.00% | -12.14% | |
| Form 10-Q PURE BIOSCIENCE, INC. For: Jan 31 | SEC filing · Form 10-Q | +0.00% | +4.59% | |
| PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results | Press release | +0.00% | +4.59% | |
| Form 10-Q PURE BIOSCIENCE, INC. For: Oct 31 | SEC filing · Form 10-Q | +0.00% | +7.80% | |
| PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results | Press release | +0.00% | +7.80% | |
| Form 10-K PURE BIOSCIENCE, INC. For: Jul 31 | SEC filing · Form 10-K | +3.75% | -11.25% | |
| Form 10-Q PURE BIOSCIENCE, INC. For: Apr 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results | Press release | +0.00% | +0.00% | |
| Form 10-Q PURE BIOSCIENCE, INC. For: Jan 31 | SEC filing · Form 10-Q | +0.00% | -12.94% | |
| PURE Bioscience Reports Fiscal Second Quarter 2025 Financial Results | Press release | +0.00% | -12.94% | |
| Form 10-Q PURE BIOSCIENCE, INC. For: Oct 31 | SEC filing · Form 10-Q | +0.00% | +10.60% | |
| PURE Bioscience Reports Fiscal First Quarter 2025 Financial Results | Press release | +0.00% | +10.60% | |
| Form 10-K PURE BIOSCIENCE, INC. For: Jul 31 | SEC filing · Form 10-K | — | — | |
| Form 10-Q PURE BIOSCIENCE, INC. For: Apr 30 | SEC filing · Form 10-Q | +0.00% | +13.53% | |
| PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results | Press release | +0.00% | +13.53% | |
| Form 10-Q PURE BIOSCIENCE, INC. For: Jan 31 | SEC filing · Form 10-Q | +0.05% | -11.51% | |
| PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results | Press release | +0.05% | -11.51% | |
| Form 10-Q PURE BIOSCIENCE, INC. For: Oct 31 | SEC filing · Form 10-Q | +0.00% | +25.00% | |
| PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results | Press release | +0.00% | +25.00% | |
| Form 10-K PURE BIOSCIENCE, INC. For: Jul 31 | SEC filing · Form 10-K | +0.00% | -19.00% |
Keep exploring
More PURE: analyst actions → · SEC filings → · PURE overview →
Other Consumer Defensive names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| 111, Inc. - American Depositary Shares (YI) | 78 | -0.92% | 35% |
| AFFINOR GROWERS INC (RSSFF) | 76 | 0.00% | 39% |
| Bright Scholar Education Holdings Limited American Depositary Shares, each representing four Class A Ordinary Share (BEDU) | 73 | 0.00% | 44% |
| Mayfair Gold Corp. Common Shares (MINE) | 73 | +0.43% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.